Drug
Arikayce
Arikayce: highest development phase Phase 2, developed by Insmed. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Insmed
Trials
| Drug | Phase | Indication |
|---|---|---|
| Arikayce™ NCT03905642 | Phase 2 | Cystic Fibrosis |
| Arikayce™ 560 mg NCT00558844 | Phase 1/2 | Cystic Fibrosis |
Latest
No recent events.
Follow Arikayce on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.